We are live on
!
Find out more
MCM
Moore Capital Management Portfolio holdings
AUM
$4.92B
1-Year Est. Return
35.41%
This Fund
S&P 500
This Quarter
Est. Return
+4.98%
1 Year Est. Return
+35.41%
3 Year Est. Return
+169.06%
5 Year Est. Return
+282.2%
10 Year Est. Return
+2,041.62%
AUM
$5.04B
AUM Growth
-$1.51B
(-23%)
Cap. Flow
-$1.73B
Cap. Flow
% of AUM
-34.29%
Top 10 Holdings %
Top 10 Hldgs %
28.18%
Holding
958
New
171
Increased
45
Reduced
92
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$161M |
| 2 |
Amazon
AMZN
|
+$62.2M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$51.8M |
| 4 |
MGIC Investment
MTG
|
+$48.3M |
| 5 |
DexCom
DXCM
|
+$33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$98.6M |
| 2 |
Moderna
MRNA
|
+$73.1M |
| 3 |
Canadian National Railway
CNI
|
+$72.9M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$69.7M |
| 5 |
Coupang
CPNG
|
+$60.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.56% |
| 2 | Technology | 10.69% |
| 3 | Consumer Discretionary | 9.59% |
| 4 | Industrials | 9.05% |
| 5 | Healthcare | 6.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Magna International
MGA
$18.8B
| $33.8M | 0.67% |
417,428
-534,619
| -56% | -$43.5M |
|
|
TPGY
27
DELISTED
TPG Pace Beneficial Finance Corp.
TPGY
| $30.8M | 0.61% |
3,140,816
| – | – |
|
|
28
DexCom
DXCM
$29B
| $30.8M | 0.61% |
+229,436
| New | +$33M |
|
29
Allstate
ALL
$70.6B
| $30.6M | 0.61% |
+260,000
| New | +$30.8M |
|
30
General Motors
GM
$80.9B
| $30.2M | 0.6% |
515,465
+60,466
| +13% | +$3.53M |
|
31
SBA Communications
SBAC
$19.8B
| $30M | 0.6% |
77,185
-26,152
| -25% | -$9.18M |
|
32
United Parcel Service
UPS
$88.9B
| $29.3M | 0.58% |
+136,759
| New | +$27.8M |
|
33
Progressive
PGR
$128B
| $26.7M | 0.53% |
+260,000
| New | +$24.8M |
|
|
SGEN
34
DELISTED
Seagen Inc. Common Stock
SGEN
| $26.4M | 0.52% |
170,966
+22,918
| +15% | +$3.84M |
|
|
MASI
35
DELISTED
Masimo
MASI
| $26.3M | 0.52% |
+89,831
| New | +$25.6M |
|
36
Freeport-McMoran
FCX
$86.2B
| $25.4M | 0.5% |
608,000
-832,469
| -58% | -$31.6M |
|
37
Intuitive Surgical
ISRG
$127B
| $24.7M | 0.49% |
+68,829
| New | +$23.7M |
|
38
S&P Global
SPGI
$124B
| $24.7M | 0.49% |
52,364
+27,807
| +113% | +$12.7M |
|
39
CALL
iShares MSCI Emerging Markets ETF
EEM
$27.5B
| $24.4M | 0.48% |
500,000
-415,000
| -45% | -$20.9M |
|
40
AstraZeneca
AZN
$269B
| $24M | 0.48% |
+205,822
| New | +$24.2M |
|
41
Boeing
BA
$169B
| $23.5M | 0.47% |
116,961
+37,970
| +48% | +$8.02M |
|
42
Alight
ALIT
$534M
| $22.8M | 0.45% |
+105,585
| New | +$22.9M |
|
43
Global Payments
GPN
$24.1B
| $22.2M | 0.44% |
+164,243
| New | +$22.6M |
|
44
Lennar Class A
LEN
$20.4B
| $21.4M | 0.43% |
+190,599
| New | +$19.5M |
|
45
CSX Corp
CSX
$94B
| $20.8M | 0.41% |
+553,631
| New | +$19.5M |
|
46
Parker-Hannifin
PH
$120B
| $20.3M | 0.4% |
63,745
+26,316
| +70% | +$8.14M |
|
47
Republic Services
RSG
$67.4B
| $20.1M | 0.4% |
+144,135
| New | +$19.2M |
|
|
LICY
48
DELISTED
Li-Cycle Holdings Corp.
LICY
| $19.9M | 0.4% |
250,000
-375,000
| -60% | -$35.4M |
|
|
CVII
49
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
| $19.7M | 0.39% |
2,000,000
| – | – |
|
50
AbbVie
ABBV
$465B
| $19.2M | 0.38% |
+141,739
| New | +$16.7M |
|
Similar funds
MSRPS
SIA
FC
SMFG
KCM
PBA
DGI
FFB
Moore Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Moore Capital Management held 958 positions worth $5.04B, down 23% from $6.55B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Moore Capital Management withdrew a net $1.73B in Q4 2021, closing 231 positions and reducing 92 holdings. Its most notable exit was Moderna, an estimated $73.1M position sold in full.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Moore Capital Management opened a new position in State Street SPDR S&P Biotech ETF worth $150M.
- Moore Capital Management's largest Q4 2021 buy was State Street SPDR S&P Biotech ETF: 1,335,600 shares worth $150M.
- Moore Capital Management added most to Amazon in Q4 2021, an estimated $62.2M increase.
- Moore Capital Management's biggest Q4 2021 reduction was Microsoft, cutting an estimated $98.6M.
- Moore Capital Management fully exited Moderna in Q4 2021, selling an estimated $73.1M.
- Moore Capital Management's ten largest holdings make up 28% of its $5.04B portfolio in Q4 2021.
- Moore Capital Management opened 171 new positions and closed 231 in Q4 2021.
- Moore Capital Management's portfolio value fell 23% quarter-over-quarter to $5.04B.
Based on Moore Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.